Calls to back the health industry for Victoria’s future
BioMelbourne Network is challenging state election candidates to adopt initiatives that make the health industry a top economic priority for Victoria.
Invention, connection, trust – key ingredients for curating innovation communities
BioMelbourne Network and The Royal Society of Victoria recently hosted the BioBreakfast Curating Innovation Communities featuring the recipients of the 2018 Women in Leadership Awards. One of our volunteers, Aleisha Symon, wrote the following summary of the event. Aleisha is…
Joint statement: The health industry as an economic priority for Victoria
September 2018 Victoria has world-leading competitive advantages in the health industry, which encompasses health and medical research, biotechnology, medical technology, pharmaceuticals, digital health, healthcare delivery, global health and health services. Victoria’s healthcare sector contributes to more than $30…
Location, location, translation: key messages from the Biotech Development Lab
Last Friday, BioMelbourne Network hosted the Molecules, Medicines and Markets Biotech Development Lab. One of our volunteers, Emma Wanicek, wrote the following summary of the event. Emma is a Research Assistant in the HIV Neuropathogenesis Laboratory in the Chronic Infectious and…
BioMelbourne Network submission regarding R&D Tax Incentive
August 2018 On behalf of the members, BioMelbourne Network has made a submission to Treasury regarding the proposed changes to the R&D Tax Incentive. In terms of our overall consideration of the proposed changes to the R&D Tax…
Women Leading World-Class Health Innovation in Melbourne
Victoria grows globally competitive innovation-intensive companies. Innovation is a people-driven process that thrives on diverse thinking and views. Now that business is embracing the performance-based argument, successful women in and those aspiring towards leadership roles need recognition to…
Australia is backing health innovation industries to build future economy
Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…
New BioMelbourne Network Board Appointment – David Herd
The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting. “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…
BioMelbourne Network gives State Budget 6/10 for the health innovation industry
BioMelbourne Network CEO Dr Krystal Evans welcomes the State Government of Victoria’s Budget yesterday, noting the significant investment in digital infrastructure, the Heart Hospital and the ongoing operational support for the Melbourne Biomedical Precinct. However, these initiatives are…
New report aims to broaden understanding of how new medicines are funded in Australia
– Stakeholders debate future of medicines funding system at launch event A new report, developed by GlaxoSmithKline Australia (GSK) and ViiV Healthcare (ViiV) will be launched as part of an initiative to raise understanding of the medicines development…
2017 – A Big Year for Biotech!
Our vision for Victoria is to lead the world in health innovation. Discovering, developing and manufacturing the health technologies that change the world. New drugs, devices, diagnostics, vaccines, therapies and digital products – Victoria is the best place to…
BioMelbourne Network submission to the Policy Consultation Paper – Visa Simplification: Transforming Australia’s Visa System
October 2017 “Australia’s visa system must remain globally competitive to attract talent to build future industries and transition to a knowledge-led economy” Health is a global market and access to global talent is critical for healthcare innovation. Companies…
